Heterologous immunization with improved HIV1 subtype C vaccines elicit Tier 2 neutralizing antibodies with rapid viral replication control after SHIV challenge
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
WOS